➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
McKinsey
Express Scripts
Harvard Business School
Moodys

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

NARATRIPTAN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Naratriptan, and when can generic versions of Naratriptan launch?

Naratriptan is a drug marketed by Ani Pharms Inc, Apotex Corp, Chartwell Rx, Heritage Pharms Inc, Hikma, Mylan Pharms Inc, Orchid Hlthcare, Paddock Llc, and Sun Pharm Inds Ltd. and is included in nine NDAs.

The generic ingredient in NARATRIPTAN is naratriptan hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the naratriptan hydrochloride profile page.

Drug patent expirations by year for NARATRIPTAN
Recent Clinical Trials for NARATRIPTAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
BioHealthonomics Inc.Phase 2
Ache Laboratorios Farmaceuticos S.A.Phase 3
Roxane LaboratoriesN/A

See all NARATRIPTAN clinical trials

US Patents and Regulatory Information for NARATRIPTAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 078751-001 Jul 7, 2010 DISCN No No   Start Trial   Start Trial   Start Trial
Heritage Pharms Inc NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 200502-001 Feb 28, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Apotex Corp NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 091373-002 Apr 22, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Pharms Inc NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 202431-002 May 31, 2012 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Mallinckrodt
Dow
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.